A Phase 2, 28-Day, Multicenter, Double-Blind,Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MB07803 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2011
At a glance
- Drugs VK 0612 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 11 Aug 2011 Company added as reported by ClinicalTrials.gov.
- 08 Aug 2008 Results to be presented at The World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, Barcelona, Spain, October 2008.
- 29 Apr 2008 Status changed from in progress to completed.